New drug injection aims to dissolve brain bleeds safely
NCT ID NCT06696131
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests whether a drug called Tenecteplase (TNK) is safe to inject directly into a brain bleed (intracerebral hemorrhage). Five adults aged 18-80 with large bleeds will receive a single dose during standard surgery. The goal is to see if TNK can dissolve the clot without causing more bleeding or other serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGIC STROKES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can blood markers predict brain injury outcomes?
- Can an ancient herbal pill improve outcomes after a bleeding stroke?
- Could a simple ear probe replace invasive brain pressure monitoring?
- Can a tiny zing to the fingers reboot the brain after stroke?
- Zapping the vagus nerve: a new hope for Stroke-Weakened arms?
- Ear nerve zaps may aid stroke recovery in kids — a tiny trial puts it to the test